We welcome Senator Brownback's recommendation to Administrator Shah to support the review process to shorten pathways fo...
It's really important for them to own this process. And we're not going to be there forever.
But, your ability to identify areas to work on----
It's my hope we can move this process on forward, and in doing that, target this.
I don't want to give somebody leadership, if you guys have worked it out internally, but it sure seems like----
Do you have any technical response or thoughts to it?
I hope you'll be willing to come to the Congress if there's statutory authority that's needed by you, NIH, AID, others, ...
I wonder if you've surveyed some of the countries and places you're working, and ask them for the top 10 priorities that...
The old model of a billion dollars to develop a drug doesn't work in this category.
I think we should really look at a key issue, which is the economics of--you know, FDA and NIH can do all the work they ...
Less than 3 percent of the rare diseases have an FDA-approved treatment.
It doesn't seem like we're getting there yet with rare and neglected diseases.
It's my hope that, in the future, when the good Samaritan story is told, it's the United States that's the one that stop...
It's just not good enough. I know we can do better than this.
I'm frustrated, because I've been working in this space for 5 or 6 years, and I'm kind of, 'All right. Where's the produ...
I want to make absolutely sure we do not repeat that, and we take all of the claims and concerns seriously.
That would be significant to some people I know--me in particular.
I am disappointed that the National Congress Party has cracked down on the media, several journalists, opposition leader...
